Cargando…

Cholesterol and its association with muscle weakness in critical illness

Detalles Bibliográficos
Autores principales:	Hofmaenner, Daniel A., Kleyman, Anna, Singer, Mervyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371860/ https://www.ncbi.nlm.nih.gov/pubmed/34404474 http://dx.doi.org/10.1186/s13054-021-03722-2

Ejemplares similares

Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis
por: Hofmaenner, Daniel A., et al.
Publicado: (2023)

Challenging management dogma where evidence is non-existent, weak or outdated
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Altered cholesterol homeostasis in critical illness-induced muscle weakness: effect of exogenous 3-hydroxybutyrate
por: Goossens, Chloë, et al.
Publicado: (2021)

The challenge of pharmacological thromboprophylaxis in ICU patients: anti-FXa activity does not constitute the simple solution. Author's reply
por: Hofmaenner, Daniel A., et al.
Publicado: (2022)

Critical illness and flat batteries
por: Singer, Mervyn
Publicado: (2017)

Muscular weakness and muscle wasting in the critically ill
por: Schefold, Joerg C., et al.
Publicado: (2020)

SUN-548 Ketone Bodies in Critical Illness Alter Cholesterol Synthesis in Skeletal Muscle, Interlinked with Protection Against Weakness
por: Goossens, Chloë, et al.
Publicado: (2020)

Risk factors associated with bloodstream infections among critically ill patients with COVID-19
por: McMillan, Tim, et al.
Publicado: (2021)

Treating Critical Illness: The Importance of First Doing No Harm
por: Singer, Mervyn, et al.
Publicado: (2005)

Multi-Organ Dysfunction in the Critically Ill: Effects on Different Organs
por: Brealey, David, et al.
Publicado: (2000)

Multi-Organ Dysfunction in the Critically Ill: Epidemiology, Pathophysiology and Management
por: Brealey, David, et al.
Publicado: (2000)

Electrical muscle stimulation for prevention of critical illness polyneuropathy
por: Rodriguez, Pablo O, et al.
Publicado: (2010)

Premorbid obesity, but not nutrition, prevents critical illness‐induced muscle wasting and weakness
por: Goossens, Chloë, et al.
Publicado: (2016)

Learning for the next pandemic: the Wuhan experience of managing critically ill people
por: Du, Bin, et al.
Publicado: (2021)

Bench-to-bedside review: The role of C1-esterase inhibitor in sepsis and other critical illnesses
por: Singer, Mervyn, et al.
Publicado: (2011)

Mitochondrial function in skeletal muscle of patients with protracted critical illness and ICU-acquired weakness
por: Jiroutková, Kateřina, et al.
Publicado: (2015)

ICU-acquired weakness: what is preventing its rehabilitation in critically ill patients?
por: Lee, Christie M, et al.
Publicado: (2012)

Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness
por: Hill, Neil E., et al.
Publicado: (2017)

Changes in muscle ultrasound for the diagnosis of intensive care unit acquired weakness in critically ill patients
por: Zhang, Weiqing, et al.
Publicado: (2021)

Transcriptomic analysis reveals abnormal muscle repair and remodeling in survivors of critical illness with sustained weakness
por: Walsh, Christopher J., et al.
Publicado: (2016)

Variability in the rectus femoris muscle area and its association with clinical outcomes in critically ill patients: a prospective cohort study
por: Magalhães, Laura Monteiro, et al.
Publicado: (2020)

Low total cholesterol blood level is correlated with pulmonary severity in COVID-19 critical ill patients
por: Ressaire, Quentin, et al.
Publicado: (2020)

Trials on oxygen targets in the critically ill patients: do they change our knowledge and practice?
por: Girardis, Massimo, et al.
Publicado: (2023)

Diaphragm weakness in mechanically ventilated critically ill patients
por: Supinski, Gerald S, et al.
Publicado: (2013)

A plea for balanced reporting
por: Singer, Mervyn
Publicado: (2010)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Pediatric critical illness associated cerebral microhemorrhages
por: Abdul Rashid, Anna Misyail, et al.
Publicado: (2019)

Upper and lower limb muscle atrophy in critically ill patients: an observational ultrasonography study
por: Nakanishi, Nobuto, et al.
Publicado: (2017)

Impaired Ca(2+) release contributes to muscle weakness in a rat model of critical illness myopathy
por: Llano-Diez, Monica, et al.
Publicado: (2016)

Insulin and the critically ill
por: Das, Undurti N
Publicado: (2002)

Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review
por: Maffiuletti, Nicola A, et al.
Publicado: (2013)

Enteral nutrition management in critically ill adult patients and its relationship with intensive care unit-acquired muscle weakness: A national cohort study
por: Zaragoza-García, Ignacio, et al.
Publicado: (2023)

Hyperglycemia and acquired weakness in critically ill patients: potential mechanisms
por: Callahan, Leigh Ann, et al.
Publicado: (2009)

Intensive care unit acquired muscle weakness in COVID-19 patients
por: Van Aerde, Nathalie, et al.
Publicado: (2020)

Cytomegalovirus reactivation in critically ill burn patients: it’s time to worry about it!
por: Bordes, Julien, et al.
Publicado: (2014)

Tissue Doppler in critical illness
por: Chew, Michelle, et al.
Publicado: (2007)

Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis
por: Damiani, Elisa, et al.
Publicado: (2014)

0030. Effect of exercise training on muscle function in a recovery model of critical illness
por: Sigurta, A, et al.
Publicado: (2014)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Advancing critical care: time to kiss the right frog
por: Singer, Mervyn
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qd3bmddd51517d6c31u84a3gu7